clinical trial · NCT06222294
A Study of Remimazolam Tosilate for Sedation in the ICU
Jiangsu HengRui Medicine Co., Ltd.·phase3·completed·n = 214
Sedation in the ICURemimazolam TosilatePropofol Medium and Long Chain Fat Emulsion Injection
brief summary
The purpose of this study is to evaluate the efficacy and safety of Remimazolam Tosilate for Injection for sedation in the ICU.
started
Mar 12, 2024
primary completion
Aug 13, 2024
completion
Sep 24, 2024
last updated
Jan 9, 2026
official title
A Multi-center, Randomized, Single-blind, Parallel Controlled With Active Drug, Phase III Clinical Trial to Evaluate the Efficacy and Safety of Remimazolam Tosilate for Injection for Sedation in the Intensive Care Unit (ICU)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol